Ask AI
Real World Challenges in MASH Management

CE / CME

Navigating Real-world Challenges in MASH Care: Sustaining Treatment Success With Long-Term Management

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: December 19, 2025

Expiration: December 18, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 72-year-old adult with obesity (BMI: 34.7 kg/m2), T2D (A1C: 8.2%), and hypertension is newly diagnosed with MASH and F2 fibrosis based on VCTE findings. Current medications include metformin, lisinopril, and simvastatin. The patient is concerned about their liver disease and asks if there is a treatment option that could help address both their liver and metabolic health. 

Which of the following is the most appropriate next step in this patient’s management?